How This MedTech Startup Is Transforming Prostate Cancer Care with AI | Interview with Artera CEO episode artwork

EPISODE · Jan 30, 2025 · 28 MIN

How This MedTech Startup Is Transforming Prostate Cancer Care with AI | Interview with Artera CEO

from Delta: HealthTech Innovators

In this exclusive interview, discover how Artera, a pioneering MedTech startup, is harnessing AI to revolutionize prostate cancer treatment and reshape the future of personalized medicine. Join me, Dr. Roupen—a physician and oncologist passionate about healthcare innovation—as I chat with Artera’s CEO, Dr. Andre Esteva. Learn how their AI-driven tests, validated by rigorous clinical trials and supported by major investors like Marc Benioff, are changing the game for both clinicians and patients.We explore how Artera secured insurance reimbursement, overcame the biggest hurdles in HealthTech, and integrated seamlessly into clinical workflows. Dr. Esteva also shares powerful insights on building cross-functional teams, fostering values-based organizational culture, and scaling efficiently in the ever-challenging startup landscape.If you’re excited about AI in Healthcare, Cancer Therapy, and digital health breakthroughs, this episode is a must-watch. Don’t miss these invaluable lessons on turning cutting-edge research into a market-ready product that truly elevates patient outcomes. Subscribe now for more inspiring conversations with industry leaders who are making a real delta in healthcare!Roupen Odabashian:LinkedIn: / roupen-odabashian-183aaa142X: / roupenmdEmail: [email protected] EstevaLinkedIn: https://www.linkedin.com/in/andre-esteva-phd-ab6b2438/0:00 - Introduction: Collaboration in healthcare innovation0:42 - Guest Introduction: Dr. Andre Esteva, CEO of Artera1:20 - Artera AI Prostate Test: Transforming cancer treatment3:09 - AI’s Early Impact: Detecting melanoma with technology5:06 - Lessons from Salesforce: Values-based company building6:49 - Artera’s Core Values: Patient success and efficiency10:38 - What is Artera?: Revolutionizing personalized medicine13:07 - AI in Oncology: Unlocking hidden insights in cancer care14:38 - Validation and Guidelines: NCCN and clinical trials15:41 - Startup Challenges: Data access and reimbursement hurdles20:00 - Funding Success: Marc Benioff’s support for Artera22:40 - Advice for Innovators: Start with a clear clinical vision27:16 - Closing Thoughts: The future of MedTech innovationWatch Our Podcast at YouTube#MedTech, #HealthTech, #Startup, #AI, #ProstateCancer, #PersonalizedMedicine, #Oncology, #DigitalHealth, #HealthcareInnovation, #AIinHealthcare, #PrecisionMedicine, #HealthcareStartup, #CancerCare, #MedicalAI, #DrRoupen, #Artera, #Innovation, #CancerTherapy, #Entrepreneurship, #techtalk

Episode metadata supplied by the publisher feed · Published Jan 30, 2025

Embed this episode

NOW PLAYING

How This MedTech Startup Is Transforming Prostate Cancer Care with AI | Interview with Artera CEO

0:00 28:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Delta: HealthTech Innovators?

This episode is 28 minutes long.

When was this Delta: HealthTech Innovators episode published?

This episode was published on January 30, 2025.

Can I download this Delta: HealthTech Innovators episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!